One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
An Objective Pain Assessment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Patient's Perspective.
An Objective Pain Assessment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Patient's Perspective.
doi : 10.2215/CJN.0000000000000043
Volume 18(2) pgs. 147-290 February 2023
Understanding Hypercoagulability with Nephrotic Syndrome: How the Clot Thickens.
Greenberg, Keiko I.; Choi, Michael J.
Leveraging Electronic Health Record to Monitor Progression of Kidney Disease in Children.
Dart, Allison
Concurrent Targeting of Vasopressin Receptor 2 and Somatostatin Receptors in Autosomal Dominant Polycystic Kidney Disease: A Promising Approach for Autosomal Dominant Polycystic Kidney Disease Treatment?.
Hogan, Marie C. 1,2; Masyuk, Tatyana V. 3,4
System-Based Solutions to Minimizing Nephrotoxin-Induced Acute Kidney Injury.
James, Matthew T. 1; Sawhney, Simon 2
A Step Ahead toward Measuring Pain in Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Steele, Cortney N.; Nowak, Kristen L.
Nephrotoxin Exposure and Acute Kidney Injury in Adults.
Griffin, Benjamin R. 1,2; Wendt, Linder 1; Vaughan-Sarrazin, Mary 1,2; Hounkponou, Hermann 1; Reisinger, Heather S. 1,2; Goldstein, Stuart L. 3; Jalal, Diana 1,2; Misurac, Jason 4
Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database.
Gluck, Caroline A. 1; Forrest, Christopher B. 2,3; Davies, Amy Goodwin 3; Maltenfort, Mitchell 3; Mcdonald, Jill R. 3; Mitsnefes, Mark 4; Dharnidharka, Vikas R. 5; Dixon, Bradley P. 6; Flynn, Joseph T. 7; Somers, Michael J. 8; Smoyer, William E. 9; Neu, Alicia 10; Hovinga, Collin A. 11; Skversky, Amy L. 12; Eissing, Thomas 12; Kaiser, Andreas 12; Breitenstein, Stefanie 12; Furth, Susan L. 2,13,14; Denburg, Michelle R. 2,13,14
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD.
Collier, Willem 1,2; Inker, Lesley A. 3; Haaland, Benjamin 1; Appel, Gerald B. 4; Badve, Sunil V. 5; Caravaca-Fontan, Fernando 6; Chalmers, John 5; Floege, Jurgen 7; Goicoechea, Marian 8; Imai, Enyu 9; Jafar, Tazeen H. 10; Lewis, Julia B. 11; Li, Philip K.T. 12; Locatelli, Francesco 13; Maes, Bart D. 14; Neuen, Brendon L. 5; Perrone, Ronald D. 3; Remuzzi, Giuseppe 15; Schena, Francesco P. 16; Wanner, Christoph 17; Heerspink, Hiddo J.L. 18; Greene, Tom 1; the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)*
Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD.
Wulczyn, Kendra E. 1; Rhee, Eugene P. 1,2; Myint, Leslie 3; Kalim, Sahir 4; Shafi, Tariq 5
doi : 10.2215/CJN.09480822
Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population.
Reynolds, Kaylia M. 1; Lin, Bridget M. 1; Armstrong, Nicole D. 2; Ottosson, Filip 3,4; Zhang, Ying 5; Williams, Ashley S. 6; Yu, Bing 7; Boerwinkle, Eric 7; Thygarajan, Bharat 8; Daviglus, Martha L. 9; Muoio, Deborah 6; Qi, Qibin 10; Kaplan, Robert 10,11; Melander, Olle 3; Lash, James P. 12; Cai, Jianwen 1; Irvin, Marguerite R. 2; Newgard, Christopher B. 6; Sofer, Tamar 5,13; Franceschini, Nora 14
doi : 10.2215/CJN.09070822
Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.
Oberdhan, Dorothee 1; Cole, Jason C. 2; Atkinson, Mark J. 3,4; Krasa, Holly B. 5; Davison, Sara N. 6; Perrone, Ronald D. 7
Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial.
Trillini, Matias 1; Caroli, Anna 1; Perico, Norberto 1; Remuzzi, Andrea 2; Brambilla, Paolo 3; Villa, Giulia 1; Perna, Annalisa 1; Peracchi, Tobia 1; Rubis, Nadia 1; Martinetti, Davide 1; Caruso, Mariarosa 4; Leone, Valentina Fanny 4; Cugini, Daniela 1; Carrara, Fabiola 1; Remuzzi, Giuseppe 1; Ruggenenti, Piero 1,4; for the TOOL Study Group
Exploring the Role of Antithrombin in Nephrotic Syndrome-Associated Hypercoagulopathy: A Multi-Cohort Study and Meta-Analysis.
Abdelghani, Eman 1,2; Waller, Amanda P. 1; Wolfgang, Katelyn J. 1; Stanek, Joseph R. 3; Parikh, Samir V. 4; Rovin, Brad H. 4; Smoyer, William E. 1,5; Kerlin, Bryce A. 1,2
Management of Intermittent Hemodialysis in the Critically Ill Patient.
Chan, Ryan J. 1; Helmeczi, Wryan 2; Canney, Mark 1,3; Clark, Edward G. 1,3
doi : 10.2215/CJN.04000422
Continuous KRT: A Contemporary Review.
Teixeira, J. Pedro 1; Neyra, Javier A. 2,3; Tolwani, Ashita 3
doi : 10.2215/CJN.04350422
Management of Patients with Kidney Failure and Pericarditis.
Rosen, Raphael J.; Valeri, Anthony M.
doi : 10.2215/CJN.07470622
The US Supreme Court and Future of Financing Dialysis Care.
Worsley, Melandrea L. 1; Erickson, Kevin F. 1,2
Implications of Antiabortion Laws on Patients with Kidney Disease in Pregnancy.
Rizzolo, Katherine 1; Faucett, Allison 2; Kendrick, Jessica 1
Kidney-Protective Effects of SGLT2 Inhibitors.
Palmer, Biff F. 1; Clegg, Deborah J. 2
doi : 10.2215/CJN.09380822
Correction: Implications of Antiabortion Laws on Patients with Kidney Disease in Pregnancy.
